These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6798669)

  • 21. Correlation of antibodies to LAV/HTLV III in hemophiliacs with the use of virus-inactivated clotting factors.
    Dietz B; Klose HJ; Gürtler L; Eberle J; Deinhardt F; Köhler-Vajta K; Peller P
    Thromb Haemost; 1986 Aug; 56(1):50-2. PubMed ID: 3095947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-cell alterations in hemophiliacs treated with commercial clotting factor concentrates.
    Lechner K; Niessner H; Bettelheim P; Deutsch E; Fasching I; Fuhrmann M; Hinterberger W; Korninger C; Neumann E; Liszka K
    Thromb Haemost; 1983 Aug; 50(2):552-6. PubMed ID: 6314582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B virus, hepatitis A virus and persistently elevated aminotransferases in hemophiliacs.
    Gerety RJ; Eyster ME; Tabor E; Drucker JA; Lusch CJ; Prager D; Rice SA; Bowman HS
    J Med Virol; 1980; 6(2):111-8. PubMed ID: 6264019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevention of transfusion-associated virus infections in hemophilic patients needing replacement therapy].
    Meili EO
    Beitr Infusionsther; 1989; 24():46-55. PubMed ID: 2481548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. False reactions in radioimmunoassay for viral hepatitis B markers in patients suffering from coagulation disorders.
    Grangeot-Keros L; Lambert T; Dubreuil P; Briantais MJ; Pillot J
    Vox Sang; 1982 Mar; 42(3):160-3. PubMed ID: 6803440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delta infection and liver disease in hemophilic carriers of hepatitis B surface antigen.
    Rizzetto M; Morello C; Mannucci PM; Gocke DJ; Spero JA; Lewis JH; Van Thiel DH; Scaroni C; Peyretti F
    J Infect Dis; 1982 Jan; 145(1):18-22. PubMed ID: 7033398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal serum transaminase levels in patients with hemophilia A.
    Cederbaum AI; Blatt PM; Levine PH
    Arch Intern Med; 1982 Mar; 142(3):481-4. PubMed ID: 6802093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modifications of factor VIII related antigen in hemophiliacs with acute hepatitis and sub-clinical liver disease.
    Sultan Y; Maisonneuve P; Simeon J; Intrator L
    Scand J Haematol Suppl; 1977; 30():16-26. PubMed ID: 267293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the AIDS epidemic.
    Evatt BL; Gomperts ED; McDougal JS; Ramsey RB
    N Engl J Med; 1985 Feb; 312(8):483-6. PubMed ID: 2982095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hepatitis in haemophilia (author's transl)].
    Stampfli K
    Ther Umsch; 1979 Apr; 36(4):322-5. PubMed ID: 377555
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatitis B surface antigen circulating immune complexes (HBsAg-CICs) in patients with bleeding disorders.
    Anh-Tuan N; Novák E; Hollán SR
    Vox Sang; 1981 Jan; 40(1):12-6. PubMed ID: 6971526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low risk for hepatitis C in hemophiliacs given a high-purity, pasteurized factor VIII concentrate. International Study Group.
    Mannucci PM; Schimpf K; Brettler DB; Ciavarella N; Colombo M; Haschke F; Lechner K; Lusher J; Weissbach G
    Ann Intern Med; 1990 Jul; 113(1):27-32. PubMed ID: 2112352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver dysfunction in haemophilia A, B and other hereditary haemorrhagic disorders.
    Ng HW
    Ann Acad Med Singap; 1984 Jul; 13(3):524-6. PubMed ID: 6335008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissociated antibody responses to the S and pre-S2 regions of the hepatitis B virus after vaccination in hemophiliacs.
    Zanetti A; Tanzi E; Mannucci PM
    J Med Virol; 1989 Jul; 28(3):156-8. PubMed ID: 2526861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AIDS and immunologic abnormalities in European and American hemophiliacs.
    Green D
    Scand J Haematol Suppl; 1984; 40():367-9. PubMed ID: 6433463
    [No Abstract]   [Full Text] [Related]  

  • 36. Retrospective study of inhibitor formation in Japanese hemophiliacs.
    Kamiya T; Takahashi I; Saito H
    Int J Hematol; 1995 Oct; 62(3):175-81. PubMed ID: 8589362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reactivation of hepatitis B in an HIV-infected patient with antibodies against hepatitis B core antigen as the only serological marker.
    Chamorro AJ; Casado JL; Bellido D; Moreno S
    Eur J Clin Microbiol Infect Dis; 2005 Jul; 24(7):492-4. PubMed ID: 15990987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment of a simple model for hepatitis B virus infection status based on trait marker from quantitative measurement of serum markers.
    Ningyu Z; Ying Z; Hui L
    J Med Virol; 2015 Jun; 87(6):1008-12. PubMed ID: 25716104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical, immunological, and virological aspects in Japanese hemophiliacs and AIDS patients.
    Abe T
    AIDS Res; 1986 Dec; 2 Suppl 1():S141-6. PubMed ID: 3103637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies to hepatitis B surface and core antigens in haemophiliacs and their contacts among hospital personnel.
    Hansson BG
    Scand J Infect Dis; 1977; 9(3):167-9. PubMed ID: 905782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.